Company intelligence / Profile preview

Skulpt

San Francisco, California, United Statesskulpt.org ↗

Ownership: Private
Employees: ~10
Development stage: Commercial

Overview

Skulpt developed handheld consumer devices using EIM technology to measure muscle quality and body fat across multiple muscle groups. The company’s products provided actionable insights for athletes and clinicians. Devices included the "Skulpt Aim" and later the "Chisel". As of 2025, device sales have been discontinued while the company reimagines its future offerings.

Therapeutic areas: OtherEndocrinologyNeurology
Modalities: Device
Industry: Physiological Monitoring

Partnerships

Collaborated with major hospitals including Boston Children's HospitalSt. Louis Children's HospitalCincinnati Children's HospitalNew England Baptist HospitalMassachusetts General Hospital

Beyond the preview

Go deeper on Skulpt.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Skulpt.

Explore the full profile